Q1 2026 saw 10.1% revenue growth and 12.2% net income increase, driven by strong B2C and premium brand performance, disciplined capital allocation, and innovation in longevity care. Outlook remains positive with continued market share gains expected.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.